736 lines
59 KiB
Text
736 lines
59 KiB
Text
<!DOCTYPE html>
|
||
<html class="no-js" lang="en" dir="ltr" prefix="content: http://purl.org/rss/1.0/modules/content/ dc: http://purl.org/dc/terms/ foaf: http://xmlns.com/foaf/0.1/ rdfs: http://www.w3.org/2000/01/rdf-schema# sioc: http://rdfs.org/sioc/ns# sioct: http://rdfs.org/sioc/types# skos: http://www.w3.org/2004/02/skos/core# xsd: http://www.w3.org/2001/XMLSchema#">
|
||
<head>
|
||
<title>Frequently Asked Questions | National Institutes of Health (NIH)</title>
|
||
<meta charset="utf-8" />
|
||
<script type="text/javascript">
|
||
//<![CDATA[
|
||
var usasearch_config = { siteHandle:"nih" };
|
||
|
||
var script = document.createElement("script");
|
||
script.type = "text/javascript";
|
||
script.src = "//search.usa.gov/javascripts/remote.loader.js";
|
||
document.getElementsByTagName("head")[0].appendChild(script);
|
||
|
||
//]]>
|
||
</script><link rel="shortcut icon" href="https://www.nih.gov/favicon.ico" type="image/vnd.microsoft.icon" />
|
||
<meta name="google-site-verification" content="rjIoO4vW0AYgltSYvxM1L_CzGIkq28kHf9gHIASKx8s" />
|
||
<link rel="profile" href="http://www.w3.org/1999/xhtml/vocab" />
|
||
<meta http-equiv="cleartype" content="on" />
|
||
<link rel="apple-touch-icon" href="https://www.nih.gov/sites/all/themes/nih/apple-touch-icon.png" />
|
||
<meta name="description" content="Frequently asked questions regarding the Regenerative Medicine Innovation Project." />
|
||
<meta name="keywords" content="regenerative, rmi, faq" />
|
||
<meta name="robots" content="follow, index" />
|
||
<meta name="viewport" content="width=device-width, initial-scale=1.0" />
|
||
<meta name="generator" content="Drupal 7 (http://drupal.org)" />
|
||
<link rel="canonical" href="https://www.nih.gov/rmi/frequently-asked-questions" />
|
||
<link rel="shortlink" href="https://www.nih.gov/node/33841" />
|
||
<meta http-equiv="content-language" content="EN" />
|
||
<meta property="og:site_name" content="National Institutes of Health (NIH)" />
|
||
<meta property="og:type" content="article" />
|
||
<meta property="og:title" content="Frequently Asked Questions" />
|
||
<meta property="og:url" content="https://www.nih.gov/rmi/frequently-asked-questions" />
|
||
<meta property="og:description" content="Frequently asked questions regarding the Regenerative Medicine Innovation Project." />
|
||
<meta property="og:updated_time" content="2022-07-26T14:28:29-04:00" />
|
||
<meta name="twitter:card" content="summary" />
|
||
<meta name="twitter:title" content="Frequently Asked Questions" />
|
||
<meta name="twitter:url" content="https://www.nih.gov/rmi/frequently-asked-questions" />
|
||
<meta name="twitter:description" content="Frequently asked questions regarding the Regenerative Medicine Innovation Project." />
|
||
<meta property="article:published_time" content="2017-04-27T16:37:42-04:00" />
|
||
<meta property="article:modified_time" content="2022-07-26T14:28:29-04:00" />
|
||
<meta name="owner" content="OD" />
|
||
<meta name="published_date" content="2017-04-27T16:37:42-04:00" />
|
||
<meta name="last_revision" content="2022-07-26T14:28:29-04:00" />
|
||
<link type="text/css" rel="stylesheet" href="https://www.nih.gov/sites/default/files/css/css_PfvPCWanzn7FjDwZqwAHhPoOxYKwkQP-RZSK1pFFG0s.css" media="all" />
|
||
<link type="text/css" rel="stylesheet" href="https://www.nih.gov/sites/default/files/css/css__mIWP9gcStq74isjZVoAAsiih8VXwJoN75Nyw_BXrj0.css" media="screen" />
|
||
<style media="print">#sb-container{position:relative;}#sb-overlay{display:none;}#sb-wrapper{position:relative;top:0;left:0;}#sb-loading{display:none;}
|
||
</style>
|
||
<link type="text/css" rel="stylesheet" href="https://www.nih.gov/sites/default/files/css/css_jENQOQqZCRFGZK__DTefxYiXR2RUf03k1ugj3_Vg7vk.css" media="all" />
|
||
<link type="text/css" rel="stylesheet" href="//cdn.jsdelivr.net/qtip2/3.0.3/jquery.qtip.min.css" media="all" />
|
||
<link type="text/css" rel="stylesheet" href="https://www.nih.gov/sites/default/files/css/css_3yt-b0M1HNJsvKsXwYjh5TEtX2lJGAvJvtmVAfORYZs.css" media="all" />
|
||
<link type="text/css" rel="stylesheet" href="//fonts.googleapis.com/css?family=Droid+Sans:700,regular|Droid+Serif:italic,regular&subset=latin" media="all" />
|
||
<link type="text/css" rel="stylesheet" href="https://www.nih.gov/sites/default/files/css/css_5rDMv37-JxnNA70cRr_1jlAjVs56DCb8EN4XB2QLl0c.css" media="all" />
|
||
|
||
<!--[if lte IE 8]>
|
||
<link type="text/css" rel="stylesheet" href="https://www.nih.gov/sites/default/files/css/css_aLJB_yHt22A_mQek4IRDNsur5tEkCpqLe72j_w6QHQ0.css" media="all" />
|
||
<![endif]-->
|
||
<link type="text/css" rel="stylesheet" href="https://www.nih.gov/sites/default/files/css/css_KviiBystpJcQq4MplcQZvCFxnu9V763f5bPq_AKh4xM.css" media="all" />
|
||
<script src="https://www.nih.gov/sites/default/files/js/js_mQAv54bz2JVXcwS5QWlz0fVY9Os67zeu9bgNqtlVLPY.js"></script>
|
||
<script src="//code.jquery.com/jquery-2.2.4.min.js"></script>
|
||
<script>window.jQuery || document.write("<script src='/sites/all/modules/contrib/jquery_update/replace/jquery/2.2/jquery.min.js'>\x3C/script>")</script>
|
||
<script>jQuery.migrateMute=true;jQuery.migrateTrace=false;</script>
|
||
<script src="//code.jquery.com/jquery-migrate-1.4.1.min.js"></script>
|
||
<script>window.jQuery && window.jQuery.migrateWarnings || document.write("<script src='/sites/all/modules/contrib/jquery_update/replace/jquery-migrate/1.4.1/jquery-migrate.min.js'>\x3C/script>")</script>
|
||
<script src="https://www.nih.gov/sites/default/files/js/js_9sGTPBGcOGZjLiSLGrYEnuUf8VdvLmL_DEZNNNbnHXk.js"></script>
|
||
<script src="https://www.nih.gov/sites/default/files/js/js_hNnF7a_sbk6nZ2-mOamHzalYND7HBHDLRInsaU93HDk.js"></script>
|
||
<script>document.createElement( "picture" );</script>
|
||
<script src="https://www.nih.gov/sites/default/files/js/js_gHk2gWJ_Qw_jU2qRiUmSl7d8oly1Cx7lQFrqcp3RXcI.js"></script>
|
||
<script src="//cdn.jsdelivr.net/qtip2/3.0.3/jquery.qtip.min.js"></script>
|
||
<script defer="defer" src="//script.crazyegg.com/pages/scripts/0011/2616.js"></script>
|
||
<script src="https://www.nih.gov/sites/default/files/js/js_M6Y5x-IfJsaieldoN31qdrl5lv71Z8XEmxbJr6rsD1Q.js"></script>
|
||
<script>
|
||
Shadowbox.path = "/sites/all/libraries/shadowbox/";
|
||
</script>
|
||
<script>jQuery.extend(Drupal.settings, {"basePath":"\/","pathPrefix":"","setHasJsCookie":0,"instances":"{\u0022default\u0022:{\u0022content\u0022:{\u0022text\u0022:\u0022\u0022},\u0022style\u0022:{\u0022tip\u0022:false,\u0022classes\u0022:\u0022\u0022},\u0022position\u0022:{\u0022at\u0022:\u0022bottom right\u0022,\u0022adjust\u0022:{\u0022method\u0022:\u0022\u0022},\u0022my\u0022:\u0022top left\u0022,\u0022viewport\u0022:false},\u0022show\u0022:{\u0022event\u0022:\u0022mouseenter \u0022},\u0022hide\u0022:{\u0022event\u0022:\u0022mouseleave \u0022}}}","qtipDebug":"{\u0022leaveElement\u0022:0}","shadowbox":{"animate":true,"animateFade":true,"animSequence":"wh","auto_enable_all_images":1,"auto_gallery":1,"autoplayMovies":true,"continuous":false,"counterLimit":10,"counterType":"default","displayCounter":true,"displayNav":true,"enableKeys":true,"fadeDuration":0.34999999999999998,"handleOversize":"resize","handleUnsupported":"link","initialHeight":160,"initialWidth":320,"language":"en","modal":false,"overlayColor":"#000","overlayOpacity":0.80000000000000004,"resizeDuration":0.55000000000000004,"showMovieControls":true,"slideshowDelay":0,"viewportPadding":20,"useSizzle":false},"picture":{"mappings":[["Sidebar media mappings","sidebar_media_mappings"],["Floated media mappings","floated_media_mappings"],["Not Set","not_set"]],"label":"Image size (required)"},"extlink":{"extTarget":"_blank","extClass":"ext","extLabel":"(link is external)","extImgClass":0,"extIconPlacement":0,"extSubdomains":1,"extExclude":"(.\\.nih\\.gov.)|(.\\.cancer\\.gov.)|(.\\.genome\\.gov.)|(.\\.drugabuse\\.gov.)|(locatorplus\\.gov.)|(.\\.govdelivery\\.com.)|(.\\.hatchbuck\\.com.)|(nihseniorhealth\\.gov.)|(clinicaltrials\\.gov.)|(search\\.usa\\.gov\\\/search\\?affiliate\\=hip.)|(search\\.gov\\\/search\\?affiliate\\=hip.)|(drugabuse\\.gov.)|(medlineplus\\.gov.)|(collegedrinkingprevention\\.gov.)|(smokefree\\.gov.)|(arpa-h\\.gov.)|(nih\\.sharepoint\\.com)","extInclude":"(.\\.pagefreezer\\.com.)","extCssExclude":".media, .emergency-message, .slideshow-main, .bean-home-slideshow-2l-block","extCssExplicit":"","extAlert":"_blank","extAlertText":"You are leaving the NIH website.\r\n\r\nThis external link provides additional information that is consistent with the intended purpose of this site. NIH cannot attest to the accuracy of a non-federal site.\r\n\r\nLinking to a non-federal site does not constitute an endorsement by NIH or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site\u2019s privacy policy when you follow the link.","mailtoClass":"mailto","mailtoLabel":"(link sends e-mail)","extUseFontAwesome":0}});</script>
|
||
|
||
<script type="application/javascript" id="uws-snippet">
|
||
// Verint Unified WebSDK Integration Snippet v2.3
|
||
//
|
||
// Instructions: please embed this snippet directly into every page of your website template.
|
||
// For optimal performance, this should be embedded directly into the template, not referenced as
|
||
// an external file.
|
||
//
|
||
// DO NOT MODIFY BELOW THIS LINE *****************************************
|
||
(function () {
|
||
var cookies = document.cookie.split("; ").reduce(function (o, i) { var p = i.split("="); o[p[0]] = p[1]; return o; }, {});
|
||
var containerValue = cookies.uws_container_override && JSON.parse(decodeURIComponent(cookies.uws_container_override));
|
||
var config = {
|
||
moduleHost: "ucm-us.verint-cdn.com",
|
||
configHost: "ucm-us.verint-cdn.com",
|
||
siteKey: "nih-gov",
|
||
container: containerValue || "live",
|
||
loadTime: Date.now()
|
||
};
|
||
var readyCallbacks = []; window.uwsReady = function (callback) { readyCallbacks.push(callback); };
|
||
var sdkPath = "//" + [config.moduleHost, "files/sites", config.siteKey, config.container, "sdk.js"].join("/");
|
||
var script = document.createElement("script"); script.src = sdkPath; script.async = true; script.type = "module";
|
||
script.addEventListener("load", function () { window.unifiedSDK.start(config, readyCallbacks); });
|
||
document.head.appendChild(script);
|
||
})();
|
||
// DO NOT MODIFY ABOVE THIS LINE *****************************************
|
||
</script>
|
||
|
||
</head>
|
||
<body class="html not-front not-logged-in page-node page-node- page-node-33841 node-type-nih-initiatives- section-rmi">
|
||
<a href="#main-content" class="element-invisible element-focusable">Skip to main content</a>
|
||
<noscript aria-hidden="true"><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-5CBCNW2" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
|
||
<div class="l-page has-one-sidebar has-sidebar-first">
|
||
|
||
<div class="l-page-content">
|
||
|
||
<header class="l-header" role="banner">
|
||
<div class="l-ribbon-wrapper">
|
||
<ul class="l-ribbon">
|
||
<li><span class="ribbon-hhs"></span><a href="https://www.hhs.gov">U.S. Department of Health & Human Services</a><span class="ribbon-right"></span></li>
|
||
</ul>
|
||
</div> <div class="l-banner-wrapper">
|
||
<div class="l-banner">
|
||
<div class="l-branding">
|
||
<a class="nih-logo icon-nih-logo" href="/" title="National Institutes of Health (NIH) - Turning Discovery into Health" rel="home"><img src="/sites/all/themes/nih/images/nih-logo-color.png" width="390" height="60" alt="National Institutes of Health (NIH) - Turning Discovery into Health" /></a>
|
||
</div>
|
||
<!-- DigitalGov Search -->
|
||
<form accept-charset="UTF-8" action="https://search.nih.gov/search" id="search" class="search-form site-search" method="get">
|
||
<div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="✓" /></div>
|
||
<input id="affiliate" name="affiliate" type="hidden" value="nih" />
|
||
<label for="query" class="hide">Search the NIH Website</label>
|
||
<input autocomplete="on" class="usagov-search-autocomplete form-field form-field-site-search" id="query" name="query" type="text" placeholder="Search NIH" /><input type="submit" name="commit" value="Search" class="form-button form-button-site-search" />
|
||
</form>
|
||
<ul class="banner-utilities">
|
||
<li><a href="/virtual-tour">Virtual Tour</a></li>
|
||
<li><a href="https://ned.nih.gov/">Staff Directory</a></li>
|
||
<li><a href="https://salud.nih.gov">En Español</a></li>
|
||
</ul>
|
||
</div>
|
||
</div>
|
||
</header>
|
||
|
||
<div class="l-navigation-wrapper">
|
||
<!-- ****************** SITE MENU ****************** -->
|
||
<h2 class="element-invisible">Site Menu</h2>
|
||
<nav class="l-menu-wrapper">
|
||
<ul class="l-menu">
|
||
<!-- ********* HOME TAB (Mobile view only) ********* -->
|
||
<li class="tab-wrapper tab-wrapper-home">
|
||
<div class="tab home"><a href="/"><span>Home</span></a></div>
|
||
</li>
|
||
<!-- ********* HEALTH INFO TAB ********* -->
|
||
<li class="tab-wrapper tab-wrapper-healthinfo tab-wrapper-left">
|
||
<div class="tab"><a href="/health-information"><span>Health Information</span></a></div>
|
||
<div class="megamenu">
|
||
<div class="megamenu-col megamenu-leftcol">
|
||
<ul class="sub-menu">
|
||
<li><a href="https://www.hhs.gov/programs/social-services/health-care-facilities/index.html">Health Care Providers & Facilities</a></li>
|
||
<li><a href="/health-information/health-info-lines">Health Info Lines</a></li>
|
||
<li><a href="https://www.healthcare.gov">HealthCare.gov</a></li>
|
||
<li><a href="/research-training/science-education">Science Education Resources</a></li>
|
||
<li><a href="/health-information/nih-clinical-research-trials-you">NIH Clinical Research Trials and You</a></li>
|
||
<li><a href="/institutes-nih/nih-office-director/office-communications-public-liaison/clear-communication/talking-your-doctor">Talking to Your Doctor</a></li>
|
||
<!--<li><a href="/institutes-nih/nih-office-director/office-communications-public-liaison/clear-communication/clear-health-nih" title="">Clear Health A–Z</a></li>-->
|
||
</ul>
|
||
<p class="more-wrapper"><a class="button gold" href="/health-information" title="More Health Information">More »</a></p>
|
||
</div>
|
||
<div class="megamenu-col megamenu-rightcol">
|
||
<form id="hipsearch" accept-charset="UTF-8" action="https://search.nih.gov/search" method="get" class="search-form">
|
||
<p class="subhead"><label for="query2">Search Health Topics</label></p>
|
||
<div class="input-wrapper">
|
||
<div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="✓" /></div>
|
||
<input id="affiliate" name="affiliate" type="hidden" value="hip" />
|
||
<input type="hidden" name="dc" value="940" />
|
||
<input autocomplete="on" maxlength="50" class="usagov-search-autocomplete form-field form-field-search" id="query2" name="query" type="text" />
|
||
<input name="commit" type="submit" value="Go" id="searchbutton" class="form-button" />
|
||
</div>
|
||
</form>
|
||
<p class="subhead">Quick Links</p>
|
||
<ul class="sub-menu">
|
||
<li><a class="minibadge minibadge-medlineplus" href="https://medlineplus.gov/"><span class="minibadge-text">MedlinePlus Health Info</span></a></li>
|
||
<li><a class="minibadge minibadge-newsinhealth" href="https://newsinhealth.nih.gov/"><span class="minibadge-text">NIH News in Health</span></a></li>
|
||
<li><a class="minibadge minibadge-wellnesstoolkits" href="/health-information/your-healthiest-self-wellness-toolkits"><span class="minibadge-text">Wellness Toolkits</span></a></li>
|
||
</ul>
|
||
</div>
|
||
</div>
|
||
</li>
|
||
<!-- ********* GRANTS TAB ********* -->
|
||
<li class="tab-wrapper tab-wrapper-grants tab-wrapper-left">
|
||
<div class="tab"><a href="/grants-funding"><span>Grants & Funding</span></a></div>
|
||
<div class="megamenu">
|
||
<div class="megamenu-col megamenu-leftcol">
|
||
<ul>
|
||
<li><a href="https://grants.nih.gov">Grants Home Page</a></li>
|
||
<li><a href="https://grants.nih.gov/funding/index.htm">Find Funding</a></li>
|
||
<li><a href="https://grants.nih.gov/grants/how-to-apply-application-guide/due-dates-and-submission-policies/due-dates.htm">Due Dates</a></li>
|
||
<li><a href="https://grants.nih.gov/grants/how-to-apply-application-guide.html">How to Apply</a></li>
|
||
<li><a href="https://grants.nih.gov/grants/about_grants.htm">About Grants</a></li>
|
||
<li><a href="https://grants.nih.gov/policy/index.htm">Policy & Compliance</a></li>
|
||
<li><a href="https://nexus.od.nih.gov/all/">Grants News/Blog</a></li>
|
||
<li><a href="https://grants.nih.gov/funding/contracts.htm">Contracts</a></li>
|
||
<li><a href="https://www.lrp.nih.gov/">Loan Repayment</a></li>
|
||
</ul>
|
||
<p class="more-wrapper"><a class="button gold" href="/grants-funding" title="More Grants & Funding Information">More »</a></p>
|
||
</div>
|
||
<div class="megamenu-col megamenu-rightcol">
|
||
<p class="subhead">Quick Links</p>
|
||
<ul>
|
||
<li><a class="minibadge minibadge-report" href="https://report.nih.gov/"><span class="minibadge-text">RePORT</span></a></li>
|
||
<li><a class="minibadge minibadge-era" href="https://commons.era.nih.gov/commons/"><span class="minibadge-text">eRA Commons</span></a></li>
|
||
<li><a class="minibadge minibadge-commonfund" href="https://commonfund.nih.gov/"><span class="minibadge-text">NIH Common Fund</span></a></li>
|
||
</ul>
|
||
</div>
|
||
</div>
|
||
</li>
|
||
<!-- ********* NEWS TAB ********* -->
|
||
<li class="tab-wrapper tab-wrapper-news tab-wrapper-left">
|
||
<div class="tab"><a href="/news-events"><span>News & Events</span></a></div>
|
||
<div class="megamenu">
|
||
<div class="megamenu-col megamenu-leftcol">
|
||
<ul>
|
||
<li><a href="/news-events/news-releases">News Releases</a></li>
|
||
<li><a href="/news-events/digital-media-kits">Digital Media Kits</a></li>
|
||
<li><a href="/news-events/media-resources">Media Resources</a></li>
|
||
<li><a href="/news-events/media-contacts">Media Contacts</a></li>
|
||
<li><a href="/news-events/images-b-roll">Images and B-roll</a></li>
|
||
<li><a href="/news-events/events">Events</a></li>
|
||
<li><a href="/news-events/social-media-outreach">Social Media</a></li>
|
||
</ul>
|
||
<p class="more-wrapper"><a class="button gold" href="/news-events" title="More News & Events">More »</a></p>
|
||
</div>
|
||
<div class="megamenu-col megamenu-rightcol">
|
||
<p class="subhead">Quick Links</p>
|
||
<ul>
|
||
<li><a class="minibadge minibadge-newsinhealth" href="https://newsinhealth.nih.gov/"><span class="minibadge-text">NIH News in Health</span></a></li>
|
||
<li><a class="minibadge minibadge-researchmatters" href="/news-events/nih-research-matters"><span class="minibadge-text">NIH Research Matters</span></a></li>
|
||
<li><a class="minibadge minibadge-nihrecord" href="https://nihrecord.nih.gov/"><span class="minibadge-text">NIH Record</span></a></li>
|
||
</ul>
|
||
</div>
|
||
</div>
|
||
</li>
|
||
<!-- ********* RESEARCH TAB ********* -->
|
||
<li class="tab-wrapper tab-wrapper-research tab-wrapper-right">
|
||
<div class="tab"><a href="/research-training"><span>Research & Training</span></a></div>
|
||
<div class="megamenu">
|
||
<div class="megamenu-col megamenu-leftcol">
|
||
<ul>
|
||
<li><a href="/research-training/medical-research-initiatives">Medical Research Initiatives</a></li>
|
||
<li><a href="/research-training/science-highlights">Science Highlights</a></li>
|
||
<li><a href="/research-training/science-education">Science Education</a></li>
|
||
<li><a href="/research-training/research-nih-labs-clinics">Research in NIH Labs & Clinics</a></li>
|
||
<li><a href="/research-training/training-opportunities">Training Opportunities</a></li>
|
||
<li><a href="/research-training/library-resources">Library Resources</a></li>
|
||
<li><a href="/research-training/research-resources">Research Resources</a></li>
|
||
<li><a href="/research-training/clinical-research-resources">Clinical Research Resources</a></li>
|
||
<li><a href="/research-training/safety-regulation-guidance">Safety, Regulation and Guidance</a></li>
|
||
</ul>
|
||
<p class="more-wrapper"><a class="button gold" href="/research-training" title="More Research & Training">More »</a></p>
|
||
</div>
|
||
<div class="megamenu-col megamenu-rightcol">
|
||
<p class="subhead">Quick Links</p>
|
||
<ul>
|
||
<li><a class="minibadge minibadge-pubmed" href="https://pubmed.ncbi.nlm.nih.gov"><span class="minibadge-text">PubMed</span></a></li>
|
||
<li><a class="minibadge minibadge-stemcell" href="https://stemcells.nih.gov"><span class="minibadge-text">Stem Cell Information</span></a></li>
|
||
<li><a class="minibadge minibadge-oppnet" href="https://oppnet.nih.gov"><span class="minibadge-text">OppNet</span></a></li>
|
||
<li><a class="minibadge minibadge-nidb" href="https://intramural.nih.gov"><span class="minibadge-text">NIDB</span></a></li>
|
||
<li><a class="minibadge minibadge-nihblueprint" href="https://neuroscienceblueprint.nih.gov"><span class="minibadge-text">NIH Blueprint for Neuroscience Research</span></a></li>
|
||
</ul>
|
||
</div>
|
||
</div>
|
||
</li>
|
||
<!-- ********* INSTITUTES TAB ********* -->
|
||
<li class="tab-wrapper tab-wrapper-institutes tab-wrapper-right">
|
||
<div class="tab"><a href="/institutes-nih"><span>Institutes at NIH</span></a></div>
|
||
<div class="megamenu">
|
||
<div class="megamenu-col megamenu-leftcol">
|
||
<ul>
|
||
<li><a href="/institutes-nih/list-institutes-centers">List of Institutes and Centers</a></li>
|
||
<li><a href="/institutes-nih/nih-office-director">NIH Office of the Director</a></li>
|
||
<li><a href="/institutes-nih/directors-nih-institutes-centers">Directors of NIH Institutes and Centers</a></li>
|
||
<li><a href="/institutes-nih/nih-institute-center-contact-information">NIH Institute and Center Contact Information</a></li>
|
||
</ul>
|
||
<p class="more-wrapper"><a class="button gold" href="/institutes-nih" title="More About the Institutes at NIH">More »</a></p>
|
||
</div>
|
||
<div class="megamenu-col megamenu-rightcol">
|
||
<p class="subhead">Quick Links</p>
|
||
<ul class="ic-acronymn-list">
|
||
<li><a href="https://www.cancer.gov" title="National Cancer Institute">NCI</a></li>
|
||
<li><a href="https://nei.nih.gov" title="National Eye Institute">NEI</a></li>
|
||
<li><a href="https://www.nhlbi.nih.gov" title="National Heart, Lung, and Blood Institute">NHLBI</a></li>
|
||
<li><a href="https://www.genome.gov" title="National Human Genome Research Institute">NHGRI</a></li>
|
||
<li><a href="https://www.nia.nih.gov" title="National Institute on Aging">NIA</a></li>
|
||
<li><a href="https://www.niaaa.nih.gov" title="National Institute on Alcohol Abuse and Alcoholism">NIAAA</a></li>
|
||
<li><a href="https://www.niaid.nih.gov" title="National Institute of Allergy and Infectious Diseases">NIAID</a></li>
|
||
<li><a href="https://www.niams.nih.gov" title="National Institute of Arthritis and Musculoskeletal and Skin Diseases">NIAMS</a></li>
|
||
<li><a href="https://www.nibib.nih.gov" title="National Institute of Biomedical Imaging and Bioengineering">NIBIB</a></li>
|
||
<li><a href="https://www.nichd.nih.gov" title="Eunice Kennedy Shriver National Institute of Child Health and Human Development">NICHD</a></li>
|
||
<li><a href="https://www.nidcd.nih.gov" title="National Institute on Deafness and Other Communication Disorders">NIDCD</a></li>
|
||
<li><a href="https://www.nidcr.nih.gov" title="National Institute of Dental and Craniofacial Research">NIDCR</a></li>
|
||
<li><a href="https://www.niddk.nih.gov" title="National Institute of Diabetes and Digestive and Kidney Diseases">NIDDK</a></li>
|
||
<li><a href="https://nida.nih.gov" title="National Institute on Drug Abuse">NIDA</a></li>
|
||
<li><a href="https://www.niehs.nih.gov" title="National Institute of Environmental Health Sciences">NIEHS</a></li>
|
||
<li><a href="https://www.nigms.nih.gov" title="National Institute of General Medical Sciences">NIGMS</a></li>
|
||
<li><a href="https://www.nimh.nih.gov" title="National Institute of Mental Health">NIMH</a></li>
|
||
<li><a href="https://www.nimhd.nih.gov" title="National Institute on Minority Health and Health Disparities">NIMHD</a></li>
|
||
<li><a href="https://www.ninds.nih.gov" title="National Institute of Neurological Disorders and Stroke">NINDS</a></li>
|
||
<li><a href="https://www.ninr.nih.gov" title="National Institute of Nursing Research">NINR</a></li>
|
||
<li><a href="https://www.nlm.nih.gov" title="National Library of Medicine">NLM</a></li>
|
||
<li><a href="https://www.cc.nih.gov" title="NIH Clinical Center">CC</a></li>
|
||
<li><a href="https://www.cit.nih.gov" title="Center for Information Technology">CIT</a></li>
|
||
<li><a href="https://www.csr.nih.gov" title="Center for Scientific Review">CSR</a></li>
|
||
<li><a href="https://www.fic.nih.gov" title="Fogarty International Center">FIC</a></li>
|
||
<li><a href="https://ncats.nih.gov" title="National Center for Advancing Translational Sciences">NCATS</a></li>
|
||
<li><a href="https://nccih.nih.gov" title="National Center for Complementary and Integrative Health">NCCIH</a></li>
|
||
</ul>
|
||
</div>
|
||
</div>
|
||
</li>
|
||
<!-- ********* ABOUT TAB ********* -->
|
||
<li class="tab-wrapper tab-wrapper-about tab-wrapper-right">
|
||
<div class="tab"><a href="/about-nih"><span>About NIH</span></a></div>
|
||
<div class="megamenu">
|
||
<div class="megamenu-col megamenu-leftcol">
|
||
<ul>
|
||
<li><a href="/about-nih/who-we-are">Who We Are</a></li>
|
||
<li><a href="/about-nih/what-we-do">What We Do</a></li>
|
||
<li><a href="https://hr.nih.gov/jobs">Jobs at NIH</a></li>
|
||
<li><a href="/about-nih/visitor-information">Visitor Information</a></li>
|
||
<li><a href="/about-nih/frequently-asked-questions">Frequently Asked Questions</a></li>
|
||
<li><a href="/about-nih/contact-us">Contact Us</a></li>
|
||
<!--<li><a href="/about-nih/explore-nih">Explore NIH</a></li>-->
|
||
</ul>
|
||
<p class="more-wrapper"><a class="button gold" href="/about-nih" title="More About NIH">More »</a></p>
|
||
</div>
|
||
<div class="megamenu-col megamenu-rightcol">
|
||
<p class="subhead">Quick Links</p>
|
||
<ul>
|
||
<li><a href="/about-nih/who-we-are/nih-director">The NIH Director</a></li>
|
||
<li><a href="/virtual-tour">Take the Virtual Tour</a></li>
|
||
<li><a href="/about-nih/what-we-do/nih-turning-discovery-into-health">NIH…Turning Discovery Into Health<sup>®</sup></a></li>
|
||
<li><a href="/about-nih/what-we-do/impact-nih-research">Impact of NIH Research</a></li>
|
||
<li><a href="/about-nih/what-we-do/science-health-public-trust">Science, Health, and Public Trust</a></li>
|
||
</ul>
|
||
</div>
|
||
</div>
|
||
</li>
|
||
</ul>
|
||
<div class="tab-bkgnd"></div><!-- For pixel rounding issue -->
|
||
</nav>
|
||
<!-- ****************** END SITE MENU ****************** -->
|
||
</div>
|
||
|
||
<div class="l-main-wrapper">
|
||
<div class="l-main" id="page-content">
|
||
<h2 class="element-invisible">You are here</h2><div class="breadcrumb"><a href="/">Home</a> » <a href="/research-training">Research & Training</a> » <a href="/research-training/medical-research-initiatives">Medical Research Initiatives</a> » <a href="/research-training/medical-research-initiatives/cures">Cures</a> » <a href="/rmi">RMI</a></div> <div class="l-region l-region--section-header">
|
||
<div id="block-ds-extras-banner-nih-initiative-ds" class="block block--ds-extras sectionheader block--ds-extras-banner-nih-initiative-ds" id="block-ds-extras-banner-nih-initiative-ds" class="block block--ds-extras sectionheader block--ds-extras-banner-nih-initiative-ds">
|
||
|
||
|
||
<div class="content" class="block__content">
|
||
<h2><a href="/rmi">Regenerative Medicine Innovation Project</a></h2> </div>
|
||
</div>
|
||
</div>
|
||
<aside class="l-region l-region--sidebar-first">
|
||
<nav id="block-menu-block-41" role="navigation" class="block block--menu-block subnav block--menu-block-41">
|
||
<h3 class="block__title">RMI</h3>
|
||
|
||
<div class="menu-block-wrapper menu-block-41 menu-name-main-menu parent-mlid-16356 menu-level-1">
|
||
<ul class="menu"><li class="first leaf menu-mlid-17506"><a href="https://www.nih.gov/rmi/" title="">About</a></li>
|
||
<li class="leaf menu-mlid-16371"><a href="/rmi/funding-opportunities">Funding Opportunities</a></li>
|
||
<li class="leaf menu-mlid-17496"><a href="/rmi/funded-awards">Funded Awards</a></li>
|
||
<li class="leaf active menu-mlid-16381"><a href="/rmi/frequently-asked-questions" class="active">FAQ</a></li>
|
||
<li class="last leaf menu-mlid-17501"><a href="/rmi/related-sites-resources">Resources</a></li>
|
||
</ul></div>
|
||
</nav>
|
||
</aside>
|
||
<div class="l-content-wrapper">
|
||
<div class="l-content" role="main">
|
||
<a id="main-content"></a>
|
||
<div about="/rmi/frequently-asked-questions" typeof="sioc:Item foaf:Document" class="ds-1col node node--nih-initiatives- view-mode-full node--full node--nih-initiatives---full clearfix">
|
||
|
||
|
||
<h1>Frequently Asked Questions</h1><p>Click on a category name below to display a list of questions. Can't find an answer to your question? Contact us at <a href="mailto:RMIP@nih.gov">RMIP@nih.gov</a>.</p>
|
||
|
||
<div class="collapsible collapsible-with-controls">
|
||
<h3 class="collapsible-trigger">General background</h3>
|
||
|
||
<div class="collapsible-content">
|
||
<p class="collapsible-trigger"><strong>Q1. Why was the Regenerative Medicine Innovation Project launched?</strong></p>
|
||
|
||
<div class="collapsible-content">
|
||
<p>Given the tremendous potential of regenerative medicine to enhance human health and treat disease, Congress included a provision in the 21st Century Cures Act — a law passed in December 2016 to accelerate medical discovery and innovation — to support a Regenerative Medicine Innovation Project (RMIP). The RMIP aims to accelerate the field by supporting clinical research on adult stem cells while promoting the highest standards for protecting patient safety during the conduct of research. The RMIP is one of four Innovation Projects authorized under the Act; the others are the Precision Medicine Initiative (“All of Us”), the Beau Biden Cancer Moonshot, and the BRAIN Initiative.</p>
|
||
</div>
|
||
|
||
<p class="collapsible-trigger"><strong>Q2. How much funding is available for the RMIP overall?</strong></p>
|
||
|
||
<div class="collapsible-content">
|
||
<div>
|
||
<p>The 21st Century Cures Act authorizes total of $30 million for the funding of clinical research to further the field of RM using adult stem cells, including autologous cells. To amplify the benefits of these funds, the Act stipulates that the NIH, in coordination with the U.S. Food and Drug Administration (FDA), award funds contingent upon the recipient making available non-Federal contributions in an amount not less than $1 for each $1 of Federal funds provided in the award (i.e., a matching funds requirement). The availability of these funds is subject to Congressional appropriation.</p>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
|
||
<h3 class="collapsible-trigger">Available funds/number of awards</h3>
|
||
|
||
<div class="collapsible-content">
|
||
<p class="collapsible-trigger"><strong>Q3. Funding Opportunity Announcements (FOAs) were issued in July 2022 utilizing the UG3/UH3 and U01 cooperative agreements, and R34 Planning Grant Program funding mechanisms. How much money is available for these FOAs and what type of research projects are being accepted?</strong></p>
|
||
|
||
<div class="collapsible-content">
|
||
<p>NIH intends to commit total funds of up to $8,000,000 across the project periods of the FY 2023 FOAs. The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications. </p>
|
||
|
||
<p>Through the relevant FOAs, NIH is accepting applications that propose UG3/UH3-Clinical Trials, U01-Preclinical Studies, and R34-Clinical Trial Planning Grants.</p>
|
||
</div>
|
||
|
||
<p class="collapsible-trigger"><strong>Q4. How many RMIP awards does NIH anticipate making under the July 2022 FOAs?</strong></p>
|
||
|
||
<div class="collapsible-content">
|
||
<div>
|
||
<p>NIH intends to commit total funds of up to $8,000,000 across the project periods of all three FOAs and anticipates issuing up to 3 awards for UG3/UH3-Clinical Trials, up to 10 awards for U01-Preclinical Studies, and up to 10 awards for R34-Clinical Trial Planning Grants. The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications. </p>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
|
||
<h3 class="collapsible-trigger">Types of awards</h3>
|
||
|
||
<div class="collapsible-content">
|
||
<p class="collapsible-trigger"><strong>Q5. What funding mechanism will these RMIP awards utilize?</strong></p>
|
||
|
||
<div class="collapsible-content">
|
||
<p><strong>Awards will utilize the following funding mechanisms:</strong></p>
|
||
|
||
<ul>
|
||
<li> Investigator-Initiated Clinical Trials (UG3/UH3 - Clinical Trial Required)
|
||
<ul>
|
||
<li><a href="https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-23-017.html">RFA-HL-23-017</a></li>
|
||
</ul>
|
||
</li>
|
||
<li>Investigator-Initiated Studies (Collaborative U01 – Clinical Trial Not Allowed)
|
||
<ul>
|
||
<li><a href="https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-23-019.html">RFA-HL-23-019</a></li>
|
||
</ul>
|
||
</li>
|
||
<li> Clinical Trial Planning Grant (R34 - Clinical Trials Not Allowed)
|
||
<ul>
|
||
<li><a href="https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-23-020.html">RFA-HL-23-020</a></li>
|
||
</ul>
|
||
</li>
|
||
</ul>
|
||
</div>
|
||
|
||
<p class="collapsible-trigger"><strong>Q6. Last year, the RMIP FOA only allowed applications for clinical trials. Is that true this year? </strong></p>
|
||
|
||
<div class="collapsible-content">
|
||
<p>No. This year, applications are being solicited for clinical trials, IND-enabling preclinical studies, and clinical trial planning activities. </p>
|
||
</div>
|
||
</div>
|
||
|
||
<h3 class="collapsible-trigger">Requirement for matching funds</h3>
|
||
|
||
<div class="collapsible-content">
|
||
<p class="collapsible-trigger"><strong>Q7. I understand that there is a matching requirement associated with these awards. What is the requirement, exactly?</strong></p>
|
||
|
||
<div class="collapsible-content">
|
||
<p>As stipulated in the 21st Century Cures Act, RMIP grantees must make non-Federal contributions to their projects in “an amount not less than $1 for each $1 of Federal funds provided in the award.” In other words, grantee contributions must be at least equal in value to the Federal dollars provided under the RMIP award. Applicants must identify the source, type, and amount of contribution(s) proposed to meet the matching requirement and explain how the value of any “in-kind” contributions was determined (see Q10).</p>
|
||
</div>
|
||
|
||
<p class="collapsible-trigger"><strong>Q8. Which of the awarded Federal funds must be matched? Must we match the total award (direct and indirect costs) or just the direct costs awarded?</strong></p>
|
||
|
||
<div class="collapsible-content">
|
||
<p>In keeping with the 21st Century Cures Act, NIH expects award recipients to match the total federally awarded amount (normally direct plus indirect costs, but see also Q11 below).</p>
|
||
</div>
|
||
|
||
<p class="collapsible-trigger"><strong>Q9. What kinds of contributions will satisfy the matching requirement?</strong></p>
|
||
|
||
<div class="collapsible-content">
|
||
<p>Matching contributions may be monetary or “in-kind” (i.e., non-monetary contributions). Matching contributions may not be from Federal sources, however, or paid for with Federal dollars. They may be in the form of funding, or paid for by funds, from non-Federal sources such as private industry, foundations, and institutional funds (not derived from Federal grants or contracts).</p>
|
||
</div>
|
||
|
||
<p class="collapsible-trigger"><strong>Q10. What do you mean by “in-kind contributions”? What are some examples of acceptable in-kind contributions?</strong></p>
|
||
|
||
<div class="collapsible-content">
|
||
<p>“In-kind” contributions are non-monetary contributions. Acceptable forms of in-kind contributions include personnel time and effort, facilities and administrative (i.e., indirect) costs, equipment, and real estate. Importantly, to be eligible, in-kind contributions must not have been obtained with support from any Federal agency.</p>
|
||
</div>
|
||
|
||
<p class="collapsible-trigger"><strong>Q11. What if we intend to forgo all reimbursement for our facilities and administrative (indirect) costs as a form of “in kind” contribution to the proposed RMIP project? Must we match what would have been the total award (direct and indirect costs), or just the direct cost amount actually awarded?</strong></p>
|
||
|
||
<div class="collapsible-content">
|
||
<p>If the institution is forgoing all indirect cost reimbursement, and consequently the NIH award is only for direct costs, then the institution must match the direct cost amount (since the 21st Century Cures Act requires matching all federally awarded dollars).</p>
|
||
</div>
|
||
|
||
<p class="collapsible-trigger"><strong>Q12. May we use revenue generated by research-related activities, such as fees charged to research participants, to fulfill the matching requirement?</strong></p>
|
||
|
||
<div class="collapsible-content">
|
||
<p>No. Such revenue is considered “program income.” Program income is not an allowable source of matching dollars. Program income is gross income earned by a recipient, a consortium participant, or a contractor under a grant that was directly generated by the grant-supported activity or earned as a result of the award. Program income includes, but is not limited to, income from fees for services performed; charges for the use or rental of real property, equipment or supplies acquired under the grant; the sale of commodities or items fabricated under an award; charges for research resources; registration fees for grant-supported conferences, and license fees and royalties on patents and copyrights.</p>
|
||
</div>
|
||
|
||
<p class="collapsible-trigger"><strong>Q13. May matching funds be obtained from a foreign government or entity?</strong></p>
|
||
|
||
<div class="collapsible-content">
|
||
<p>The 21st Century Cures Act only specifies that matching funds must be non-Federal in origin. Other policies, laws and regulations, however, may impose restrictions or requirements for funds originating from a foreign source. Before relying on such sources of money, investigators should first discuss the scenario with the appropriate agency contact listed at the end of the FOA, who can consult in turn with appropriate entities, including legal counsel, about the acceptability of the source and the requirements that may apply.</p>
|
||
</div>
|
||
|
||
<p class="collapsible-trigger"><strong>Q14. When must the matching contributions be available? All at the outset of the project? By the end of the award period? In each year that the awarded funds are drawn?</strong></p>
|
||
|
||
<div class="collapsible-content">
|
||
<p>Matching contributions must be available in each budget period in an amount at least equal to the amount of Federal dollars awarded for that period. Any matching contribution provided in excess of a given budget period’s obligation may be credited toward the following budget period’s matching obligation.</p>
|
||
|
||
<p>For applications to the UG3/UH3 FOA, there are two budget periods: UG3 (up to one year) and UH3 (up to four years). For applications to all other FOAs, there is a single budget period: the period of the award.</p>
|
||
</div>
|
||
</div>
|
||
|
||
<h3 class="collapsible-trigger">Types of eligible research projects</h3>
|
||
|
||
<div class="collapsible-content">
|
||
<p class="collapsible-trigger"><strong>Q15. How is “regenerative medicine” defined for the purpose of the RMIP and its associated funding opportunities?</strong></p>
|
||
|
||
<div class="collapsible-content">
|
||
<p>An aim of the 21st Century Cures Act is to accelerate the development of regenerative medicine therapies, which the Act describes as including “cell therapy, therapeutic tissue engineering products, human cell and tissue products, and combination products using any such therapies or products…” RM research eligible for 21st Century Cures Act funding may encompass, for example, research on biologics (e.g., growth factors, cytokines) and biomaterials (e.g., extracellular matrix, scaffolds) that stimulate or support host adult stem cell growth, proliferation, differentiation, and function or otherwise directly act upon adult stems cells to support innate host healing mechanisms, treat disease, and/or restore function. RM research in this context is interpreted to include gene therapies that lead to a durable modification of adult stem cells.</p>
|
||
</div>
|
||
|
||
<p class="collapsible-trigger"><strong>Q16. Is basic research on stem cells eligible for these funds?</strong></p>
|
||
|
||
<div class="collapsible-content">
|
||
<p>No. Basic research is a critically important component of regenerative medicine research and is funded by other NIH programs. The 21st Century Cures Act requires that the RMIP funds be used “to award grants and contracts for clinical research to further the field of regenerative medicine using adult stem cells, including autologous stem cells” (see Q17 below).</p>
|
||
</div>
|
||
|
||
<p class="collapsible-trigger"><strong>Q17. If only clinical research applications are eligible for funding under the RMIP, how is “clinical research” defined for this purpose?</strong></p>
|
||
|
||
<div class="collapsible-content">
|
||
<p>Per the FOA, proposed projects will be considered clinical research if they involve: (1) human subjects and/or (2) material of human origin, such as cells, tissues, and specimens.</p>
|
||
</div>
|
||
|
||
<p class="collapsible-trigger"><strong>Q18. Is research using cells from previously approved human embryonic stem cell lines eligible for these funds?</strong></p>
|
||
|
||
<div class="collapsible-content">
|
||
<p>No. The 21st Century Cures Act stipulates that these funds are to be used for regenerative medicine research using <em>adult</em> stem cells. For the purpose of research conducted with the RMIP funds, adult stem cells may not be derived from human embryonic or fetal sources.</p>
|
||
</div>
|
||
|
||
<p class="collapsible-trigger"><strong>Q19. May RMIP funds be used to support research with induced pluripotent stem cells (iPSCs)?</strong></p>
|
||
|
||
<div class="collapsible-content">
|
||
<p>Research with human iPSCs is eligible for RMIP funding, provided the stem cells were not derived from embryonic or fetal cells.</p>
|
||
</div>
|
||
|
||
<p class="collapsible-trigger"><strong>Q20. Is research using human neonatal stem cells eligible for these funds?</strong></p>
|
||
|
||
<div class="collapsible-content">
|
||
<p>Yes. Human neonatal stems cells (e.g., cells derived from foreskin) are considered adult stem cells for the purpose of this funding opportunity since they are not derived from fetal or embryonic sources.</p>
|
||
</div>
|
||
|
||
<p class="collapsible-trigger"><strong>Q21. Is research that aims to develop products that stimulate human host stem cell growth and function eligible for these awards?</strong></p>
|
||
|
||
<div class="collapsible-content">
|
||
<p>Yes. Eligible projects encompass, for example, research on biologics (e.g., growth factors, cytokines) and biomaterials (e.g., extracellular matrix, scaffolds) that stimulate or support host (i.e., endogenous) adult stem cell growth, self-renewal, proliferation, differentiation, and function or otherwise directly act upon adult stems cells to support innate host healing mechanisms, treat disease, and/or restore function.</p>
|
||
</div>
|
||
|
||
<p class="collapsible-trigger"><strong>Q22. Is work involving only animal models with animal stem cells eligible for these funds?</strong></p>
|
||
|
||
<div class="collapsible-content">
|
||
<p>No. Research using only animal models would only be eligible if it entailed the testing of adult stem cells of human origin in those models. Research using only animal models and animal stem cells is not eligible because it is not “clinical research” as described in the FOAs.</p>
|
||
</div>
|
||
|
||
<p class="collapsible-trigger"><strong>Q23. To be eligible for the RMIP clinical trial awards, must my project always involve a product that is under an authorized IND application or approved IDE application for administering the product to humans?</strong></p>
|
||
|
||
<div class="collapsible-content">
|
||
<p>Not necessarily. Certain types of clinical trials eligible for RMIP funding may not legally require IND authorization or IDE approval. Furthermore, three of the four award mechanisms being utilized are for research that does not involve a clinical trial (and hence, in those cases, an IND or IDE application is not required); the mechanisms being used for preclinical research are focused on late-stage or IND/IDE enabling research. See also Q26 below.</p>
|
||
</div>
|
||
|
||
<p class="collapsible-trigger"><strong>Q24. If I am proposing a clinical trial requiring IND authorization or IDE approval, when must I obtain it?</strong></p>
|
||
|
||
<div class="collapsible-content">
|
||
<p>Successful applicants must provide evidence of having had an <a href="https://www.fda.gov/vaccines-blood-biologics/industry-biologics/interact-meetings" target="_blank">INTERACT</a> consultation and/or pre-IND consultation with FDA ideally by time of application, but no later than the time of award. Before transitioning from UG3 to UH3 phase, applicants must obtain an Investigational New Drug (IND) authorization or Investigational New Device Exemption (IDE) approval to administer the product to humans</p>
|
||
</div>
|
||
|
||
<p class="collapsible-trigger"><strong>Q25. I see in the preclinical FOAs (U01) that there is a requirement for the applicant to have been in dialogue with FDA regarding a future IND or IDE. What type of information do I need to submit in my application to document this?</strong></p>
|
||
|
||
<div class="collapsible-content">
|
||
<p>Applicants should describe their <a href="https://www.fda.gov/BiologicsBloodVaccines/ResourcesforYou/Industry/ucm611501.htm">interactions with FDA</a>, including the dates of any pre-IND meetings and other communications.</p>
|
||
</div>
|
||
|
||
<p class="collapsible-trigger"><strong>Q26. I am using an autologous adult stem cell product that I believe is not subject to IND authorization or IDE approval. To submit a responsive application, what is required of me in terms of obtaining confirmation from FDA on this point?</strong></p>
|
||
|
||
<div class="collapsible-content">
|
||
<p>If the protocol is judged by the applicant to not require an IND/IDE, the applicant should provide a written explanation accompanied by documentation from FDA. Applicants are encouraged to consult with FDA early on in the process for an authoritative opinion that their product is exempt from the IND/IDE requirements by submitting a request for designation (RFD) to obtain a formal FDA determination of their cell product (see instructions at <a href="https://www.fda.gov/RegulatoryInformation/Guidances/ucm126053.htm">https://www.fda.gov/RegulatoryInformation/Guidances/ucm126053.htm</a>). Please note that if the protocol is exempt from the requirement to file an IND or IDE application, RMIP applicants are required to provide to NIH — prior to award — a copy of a formal designation letter from FDA.</p>
|
||
</div>
|
||
</div>
|
||
|
||
<h3 class="collapsible-trigger">Role of FDA</h3>
|
||
|
||
<div class="collapsible-content">
|
||
<p class="collapsible-trigger"><strong>Q27. The Act directs NIH to award funding “…in coordination with FDA.” How will this coordination be achieved?</strong></p>
|
||
|
||
<div class="collapsible-content">
|
||
<p>FDA is an essential partner and collaborator with NIH on the implementation of the RMIP. As such, FDA provides critical input on the state of regenerative medicine science, including the current knowledge gaps and technical, scientific, and operational challenges, especially with respect to regulatory science needs. NIH has worked with FDA on the development of the FOAs, including the design of the review criteria and process. FDA staff may participate as observers on the initial review panels assessing the scientific merits of the applications.</p>
|
||
</div>
|
||
</div>
|
||
|
||
<h3 class="collapsible-trigger">Regenerative Medicine Innovation Catalyst</h3>
|
||
|
||
<div class="collapsible-content">
|
||
<p class="collapsible-trigger"><strong>Q28. What is the Regenerative Medicine Innovation Catalyst (RMIC)?</strong></p>
|
||
|
||
<div class="collapsible-content">
|
||
<p>The RMIC is a resource that is being established and will be funded by NIH to catalyze the efficient development of safe and effective adult stem cell-based therapies and to further the field of regenerative medicine. The RMIC will offer services and resources to RMIP investigators to facilitate the conduct of their studies. Ultimately, the activities of the RMIC will also allow a deeper understanding of stem cell clinical products, in part by facilitating the correlation of cell characterization with clinical outcomes data. Toward these ends, it is anticipated that the RMIC will:</p>
|
||
|
||
<ul>
|
||
<li>Conduct in-depth and independent characterization of the source stem cell line and stem cell products being administered to research subjects (see Q30 and Q31)</li>
|
||
<li>Provide storage and dissemination services for in-depth cell characterization results and clinical data</li>
|
||
</ul>
|
||
|
||
<div>
|
||
<p>Operational details will be forthcoming regarding how RMIP awardees may avail themselves of the RMIC’s services.</p>
|
||
</div>
|
||
</div>
|
||
|
||
<p class="collapsible-trigger"><strong>Q29. What must RMIP awardees provide to the RMIC as a condition of their award?</strong></p>
|
||
|
||
<div class="collapsible-content">
|
||
<p>RMIP awardees will be expected to provide: (1) representative samples of the source stem cell line, (2) representative samples of the clinical-grade stem cell product, and when applicable (3) individual participant-level data emanating from an RMIP-funded clinical trial. Details about timeframes and procedures will be negotiated with individual recipients at the time of award.</p>
|
||
</div>
|
||
|
||
<p class="collapsible-trigger"><strong>Q30. Why am I expected to submit cell samples to the RMIC for characterization, and what types of analyses will be done? Will my intellectual property be protected in the process?</strong></p>
|
||
|
||
<div class="collapsible-content">
|
||
<p>While our understanding of stem cell biology is progressing rapidly, it is nonetheless widely acknowledged that a critical challenge in the development of stem cell therapies is the need for a more complete characterization of the biological attributes of stem cell products. Such in-depth characterization would enable a fuller understanding of how clinical outcomes may be related to particular cell characteristics and may inform future product development and enhance reproducibility of subsequent studies. Towards these ends, RMIP grantees will be asked to submit representative samples from their source cells, as well as the clinical-grade cell products derived from them, to an NIH-designated in-depth cell characterization platform provider for in-depth analysis of cell characteristics. The NIH-designated provider will conduct in-depth analyses of cell surface markers, -omics characteristics and other assays as appropriate. NIH recognizes that commercialization is important to developing products that will ultimately be made available to the public, and thus any proprietary information provided will be protected to the extent possible under the law.</p>
|
||
</div>
|
||
|
||
<p class="collapsible-trigger"><strong>Q31. What will be done with the cell characterization results? Will investigators be expected to modify their study protocols in response to these results? Will the assay results be shared broadly?</strong></p>
|
||
|
||
<div class="collapsible-content">
|
||
<p>Investigators will receive the in-depth cell characterization results on the cell samples that they provide. However, the biologic and clinical significance of various cell characteristics for efficacy and safety may not be known for some time, since making that correlation will require additional data, study and analysis. Thus, the primary purpose of conducting the cell characterization studies is to inform future research activities and the field at large. In-depth cell characterization assay results are not intended to inform clinical decisions during the conduct of the clinical trial, nor are they intended to factor into the normative oversight requirements and processes (e.g., FDA, DSMB, IRB) for the source study. Investigators may nonetheless consider what the results indicate relative to their scientific approach and whether any changes are warranted. In general, cell characterization assay results will be made available to the broader research community via the RMIC one year following the end of award (for preclinical studies) or the primary completion date (for clinical trials).</p>
|
||
</div>
|
||
|
||
<p class="collapsible-trigger"><strong>Q32. Will the RMIC share my clinical trial data?</strong></p>
|
||
|
||
<div class="collapsible-content">
|
||
<ul>
|
||
<li>The deidentified individual participant-level locked dataset will be shared via the RM Innovation Catalyst through controlled access as appropriate in compliance with applicable Federal laws, regulations, and policies according to the following schedule:</li>
|
||
<li>Primary outcome data will be shared one year following the primary completion date.</li>
|
||
<li>The full dataset will be shared two years following the primary completion date.</li>
|
||
</ul>
|
||
</div>
|
||
|
||
<p class="collapsible-trigger"><strong>Q33. In preparing my application, must I budget for the costs of using the RMIC’s services?</strong></p>
|
||
|
||
<div class="collapsible-content">
|
||
<p>Applicants interested in these services should consult with the appropriate NIH Scientific/Research Contact listed in the FOA as early as possible in the application process to determine the suitability of these services for their cell development process, the mechanism(s) available to fund these product development services, and whether applicants need to budget for them in their application.</p>
|
||
</div>
|
||
|
||
<p class="collapsible-trigger"><strong>Q34. Are non-RMIP awardees eligible for the RMIC services?</strong></p>
|
||
|
||
<div class="collapsible-content">
|
||
<p>Not at this time. Initially, the RMIC will only be available to the RMIP awardees. In the future, the role of the RMIC relative to other regenerative medicine studies may evolve.</p>
|
||
</div>
|
||
|
||
<p class="collapsible-trigger"><strong>Q35. The RMIP FOAs state that cell samples must be submitted to the RMIC for characterization. My project involves a product intended to stimulate the growth of endogenous (i.e., host) stem cells, and does not involve the administration of stem cells <em>per se</em> to a human. Am I subject to this sample submission requirement?</strong></p>
|
||
|
||
<div class="collapsible-content">
|
||
<p>No.</p>
|
||
</div>
|
||
</div>
|
||
|
||
<h3 class="collapsible-trigger">Review process</h3>
|
||
|
||
<div class="collapsible-content">
|
||
<p class="collapsible-trigger"><strong>Q36. How will funding decisions on these applications be made?</strong></p>
|
||
|
||
<div class="collapsible-content">
|
||
<p>As with all grant applications submitted to NIH, RMIP applications will undergo two levels of peer review: an initial review of the proposal’s scientific and technical merits, and a second level of review by an advisory council regarding funding and research priorities. Initial peer review of RMIP applications will be conducted by a Special Emphasis Panel. Final funding decisions will be made by NIH leadership.</p>
|
||
</div>
|
||
</div>
|
||
|
||
<h3 class="collapsible-trigger">More information</h3>
|
||
|
||
<div class="collapsible-content">
|
||
<p class="collapsible-trigger"><strong>Q37. Where can I get more information about the RMIP funding opportunity?</strong></p>
|
||
|
||
<div class="collapsible-content">
|
||
<p>Please visit <a href="/rmi">https://www.nih.gov/rmi</a> to find the FOAs, FAQs, and more. If you have questions about this initiative, you may also write to <a href="mailto:RMIP@nih.gov">RMIP@nih.gov</a>. Finally, you are strongly encouraged to discuss your application with the appropriate agency contact listed at the end of the FOA; early contact is important for developing a complete application and facilitating review.</p>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
|
||
</div>
|
||
|
||
<div class="lastupdated">
|
||
<p>This page last reviewed on July 26, 2022</p> </div> </div>
|
||
</div>
|
||
<div class="l-connect-wrapper">
|
||
<div class="l-connect">
|
||
<h2 class="element-invisible">Connect with Us</h2>
|
||
<ul>
|
||
<li><a class="contactus-monochrome" href="/about-nih/contact-us"><span class="icon"></span>Contact Us</a></li>
|
||
<li><a class="twitter-monochrome" href="https://twitter.com/NIH"><span class="icon"></span>X</a></li>
|
||
<li><a class="facebook-monochrome" href="https://www.facebook.com/nih.gov"><span class="icon"></span>Facebook</a></li>
|
||
<li><a class="instagram-monochrome" href="https://www.instagram.com/nihgov/"><span class="icon"></span>Instagram</a></li>
|
||
<li><a class="youtube-monochrome" href="https://www.youtube.com/user/nihod"><span class="icon"></span>YouTube</a></li>
|
||
<li><a class="flickr-monochrome" href="https://www.flickr.com/photos/nihgov/"><span class="icon"></span>Flickr</a></li>
|
||
<li><a class="social-monochrome" href="/news-events/social-media-outreach"><span class="icon"></span>More Social Media from NIH</a></li>
|
||
</ul>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
</div>
|
||
|
||
<div class="l-footer-wrapper">
|
||
<footer class="l-footer" role="contentinfo">
|
||
<h2 class="element-invisible">Footer</h2>
|
||
<ul>
|
||
<li><a href="/">NIH Home</a></li>
|
||
<li><a href="/virtual-tour">Virtual Tour</a></li>
|
||
<li><a href="https://salud.nih.gov">En Español</a></li>
|
||
<li><a href="/about-nih/visitor-information">Visitor Information</a></li>
|
||
<li><a href="/about-nih/frequently-asked-questions">Frequently Asked Questions</a></li>
|
||
<li><a href="/privacy-policy">Privacy Policy</a></li>
|
||
<li><a href="/disclaimers">Disclaimers</a></li>
|
||
<li><a href="/accessibility">Accessibility</a></li>
|
||
<li><a href="/nih-website-archives">NIH Website Archives</a></li>
|
||
</ul>
|
||
<ul>
|
||
<li><a href="/nondiscrimination-notice">Nondiscrimination Notice</a></li>
|
||
<li><a href="/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office">Freedom of Information Act</a></li>
|
||
<li><a href="https://www.edi.nih.gov/no-fear-act">No Fear Act</a></li>
|
||
<li><a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html">HHS Vulnerability Disclosure</a></li>
|
||
<li><a href="https://oig.hhs.gov">Office of Inspector General</a></li>
|
||
<li><a class="lastTab" href="https://www.usa.gov/">USA.gov</a></li>
|
||
</ul>
|
||
<p>NIH…Turning Discovery Into Health<sup>®</sup></p>
|
||
<p>National Institutes of Health, 9000 Rockville Pike, Bethesda, Maryland 20892</p>
|
||
<p><a href="https://www.hhs.gov">U.S. Department of Health and Human Services</a></p>
|
||
</footer>
|
||
</div>
|
||
|
||
<div class="back-to-top"><a href="#"><span class="icon-arrow-up"></span><span class="text">Back to Top</span></a></div>
|
||
|
||
</div>
|
||
|
||
</div>
|
||
<script src="https://www.nih.gov/sites/default/files/js/js_7Ukqb3ierdBEL0eowfOKzTkNu-Le97OPm-UqTS5NENU.js"></script>
|
||
<script src="https://www.nih.gov/sites/default/files/js/js_E9yUYWK8EMydR0HMIp2PahVxPAClXyH0Cnh782A15UM.js"></script>
|
||
</body>
|
||
</html>
|
||
|